Search Results
Search for other papers by Catalina Sierra-Ramos in
Google Scholar
PubMed
Search for other papers by Silvia Velazquez-Garcia in
Google Scholar
PubMed
Search for other papers by Arianna Vastola-Mascolo in
Google Scholar
PubMed
Search for other papers by Guadalberto Hernández in
Google Scholar
PubMed
Search for other papers by Nourdine Faresse in
Google Scholar
PubMed
Search for other papers by Diego Alvarez de la Rosa in
Google Scholar
PubMed
-induced protein sgk . PNAS 2514 – 2519 . ( https://doi.org/10.1073/pnas.96.5.2514 ) Cornier MA Dabelea D Hernandez TL Lindstrom RC Steig AJ Stob NR Van Pelt RE Wang H Eckel RH 2008 The metabolic syndrome . Endocrine Reviews 777
Search for other papers by S Otabe in
Google Scholar
PubMed
Search for other papers by N Wada in
Google Scholar
PubMed
Search for other papers by T Hashinaga in
Google Scholar
PubMed
Search for other papers by X Yuan in
Google Scholar
PubMed
Search for other papers by I Shimokawa in
Google Scholar
PubMed
Search for other papers by T Fukutani in
Google Scholar
PubMed
Search for other papers by K Tanaka in
Google Scholar
PubMed
Search for other papers by T Ohki in
Google Scholar
PubMed
Search for other papers by S Kakino in
Google Scholar
PubMed
Search for other papers by Y Kurita in
Google Scholar
PubMed
Search for other papers by H Nakayama in
Google Scholar
PubMed
Search for other papers by Y Tajiri in
Google Scholar
PubMed
Search for other papers by K Yamada in
Google Scholar
PubMed
and its circulating levels are inversely proportional to body fat content ( Arita et al . 1999 ). Thus, hypoadiponectinemia is closely associated with metabolic and cardiovascular disorders in metabolic syndrome ( Hotta et al . 2000 , Okamoto et al
Search for other papers by Renato Simões Gaspar in
Google Scholar
PubMed
Search for other papers by Renata Ohana Alves Benevides in
Google Scholar
PubMed
Search for other papers by João Lucas de Lima Fontelles in
Google Scholar
PubMed
Search for other papers by Caroline Castro Vale in
Google Scholar
PubMed
Search for other papers by Lucas Martins França in
Google Scholar
PubMed
Department of Physiology, School of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, São Paulo, Brazil
Search for other papers by Paulo de Tarso Silva Barros in
Google Scholar
PubMed
Search for other papers by Antonio Marcus de Andrade Paes in
Google Scholar
PubMed
Introduction Obesity and metabolic syndrome (MetS) have escalating prevalence worldwide and have reached an epidemic proportion, affecting the world population regardless of ethnicity or Human Development Index ( O’Neill & O’Driscoll 2015
Search for other papers by Paolo Comeglio in
Google Scholar
PubMed
Search for other papers by Ilaria Cellai in
Google Scholar
PubMed
Search for other papers by Tommaso Mello in
Google Scholar
PubMed
Search for other papers by Sandra Filippi in
Google Scholar
PubMed
Search for other papers by Elena Maneschi in
Google Scholar
PubMed
Search for other papers by Francesca Corcetto in
Google Scholar
PubMed
Search for other papers by Chiara Corno in
Google Scholar
PubMed
Search for other papers by Erica Sarchielli in
Google Scholar
PubMed
Search for other papers by Annamaria Morelli in
Google Scholar
PubMed
Search for other papers by Elena Rapizzi in
Google Scholar
PubMed
Search for other papers by Daniele Bani in
Google Scholar
PubMed
Search for other papers by Daniele Guasti in
Google Scholar
PubMed
Search for other papers by Gabriella Barbara Vannelli in
Google Scholar
PubMed
Search for other papers by Andrea Galli in
Google Scholar
PubMed
Search for other papers by Luciano Adorini in
Google Scholar
PubMed
I.N.B.B. – Istituto Nazionale Biostrutture e Biosistemi, Rome, Italy
Search for other papers by Mario Maggi in
Google Scholar
PubMed
I.N.B.B. – Istituto Nazionale Biostrutture e Biosistemi, Rome, Italy
Gynecologic Endocrinology Research Unit, Department of Experimental and Clinical Biomedical Sciences ‘Mario Serio’, University of Florence, Florence, Italy
Search for other papers by Linda Vignozzi in
Google Scholar
PubMed
Introduction Metabolic syndrome (MetS) is associated with a wide range of cardiometabolic risk conditions, including coronary heart disease, type 2 diabetes mellitus and nonalcoholic fatty liver disease (NAFLD) ( Corona et al. 2007 ). Among
Department of Biochemistry, Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Belfield, Dublin 4, Ireland
Search for other papers by S Patterson in
Google Scholar
PubMed
Department of Biochemistry, Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Belfield, Dublin 4, Ireland
Search for other papers by P R Flatt in
Google Scholar
PubMed
Department of Biochemistry, Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Belfield, Dublin 4, Ireland
Search for other papers by L Brennan in
Google Scholar
PubMed
Department of Biochemistry, Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Belfield, Dublin 4, Ireland
Search for other papers by P Newsholme in
Google Scholar
PubMed
Department of Biochemistry, Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Belfield, Dublin 4, Ireland
Search for other papers by N H McClenaghan in
Google Scholar
PubMed
subjects, especially those with impaired renal function ( Buysschaert et al. 2000 ). Diabetes is a complex disorder and a major disease of the so-called metabolic syndrome. As such, the diabetic group encompasses individuals with elevated homocysteine
Search for other papers by Umberto Simeoni in
Google Scholar
PubMed
Search for other papers by Clive Osmond in
Google Scholar
PubMed
Search for other papers by Ricardo Garay in
Google Scholar
PubMed
Search for other papers by Christophe Buffat in
Google Scholar
PubMed
Search for other papers by Farid Boubred in
Google Scholar
PubMed
Search for other papers by Christophe Chagnaud in
Google Scholar
PubMed
Search for other papers by Elisabeth Jouve in
Google Scholar
PubMed
Search for other papers by Christine Audebert in
Google Scholar
PubMed
Search for other papers by Jean-Michel Antoine in
Google Scholar
PubMed
Search for other papers by Kent Thornburg in
Google Scholar
PubMed
individual to be vulnerable for the metabolic syndrome (T2DM, high plasma triglycerides, low HDL cholesterol and hypertension) ( Barker 2000 ). Low birthweight babies have decreased muscle mass in infancy ( Robinson et al . 1991 ), a condition maintained
Division of Molecular Cardiology, Scott & White, Central Texas Veterans Health Care System, Department of Medicine, College of Medicine, Texas A&M University Health Science Center, 1901 South 1st Street, Building 205, Temple, Texas 76504, USA
Division of Molecular Cardiology, Scott & White, Central Texas Veterans Health Care System, Department of Medicine, College of Medicine, Texas A&M University Health Science Center, 1901 South 1st Street, Building 205, Temple, Texas 76504, USA
Search for other papers by Shaodong Guo in
Google Scholar
PubMed
Metabolic syndrome, also known as insulin resistance syndrome, has become a major public health problem worldwide. It consists of obesity, hyperglycemia, hyperinsulinemia, dyslipidemia, and hypertension. Metabolic syndrome is a major risk factor for
INSERM, UMR_S 1138, Teams 1, Centre de Recherche des Cordeliers, UPMC Univ Paris 06, Université Paris Descartes, Paris, France
Search for other papers by A Feraco in
Google Scholar
PubMed
Search for other papers by A Armani in
Google Scholar
PubMed
Search for other papers by R Urbanet in
Google Scholar
PubMed
Search for other papers by A Nguyen Dinh Cat in
Google Scholar
PubMed
Search for other papers by V Marzolla in
Google Scholar
PubMed
Search for other papers by F Jaisser in
Google Scholar
PubMed
Department of Human Sciences and Promotion of the Quality of Life, San Raffaele Roma Open University, Rome, Italy
Search for other papers by M Caprio in
Google Scholar
PubMed
Introduction Obesity represents a major risk factor for metabolic syndrome (MetS), which is characterized by the co-occurrence of clinical conditions strongly associated with the development of cardiovascular diseases (CDVs). Adipose tissue
Search for other papers by Salla Nuutinen in
Google Scholar
PubMed
Search for other papers by Liisa Ailanen in
Google Scholar
PubMed
Unit of Clinical Pharmacology, Turku University Hospital, Turku, Finland
Search for other papers by Eriika Savontaus in
Google Scholar
PubMed
Search for other papers by Petteri Rinne in
Google Scholar
PubMed
, has been well established in large epidemiological studies ( Kannel & McGee 1979 , Turner et al. 1998 ). In metabolic syndrome, diabetes adds the risk for cardiovascular disease and atherosclerotic complications, as metabolic syndrome with diabetes
Biomedical Research Core, Stony Brook University School of Medicine, Health Outcomes Research, Department of Molecular Behavioral Biology, Somnoquest Company Ltd., Winthrop University Hospital, 222 Station Plaza North, Suite 505-B, Mineola, New York 11501, USA
Search for other papers by Jodi F Evans in
Google Scholar
PubMed
Search for other papers by Shahidul Islam in
Google Scholar
PubMed
Search for other papers by Yoshihiro Urade in
Google Scholar
PubMed
Search for other papers by Naomi Eguchi in
Google Scholar
PubMed
Biomedical Research Core, Stony Brook University School of Medicine, Health Outcomes Research, Department of Molecular Behavioral Biology, Somnoquest Company Ltd., Winthrop University Hospital, 222 Station Plaza North, Suite 505-B, Mineola, New York 11501, USA
Search for other papers by Louis Ragolia in
Google Scholar
PubMed
features of metabolic syndrome with age independent of diet As expected, the HF diet increased body weight among both the C57BL/6 mice and the L-PGDS KO mice. Weight gain by the HF-fed L-PGDS KO mice was greater and more rapid when compared with the C57BL/6